Jeffrey T. L. Smith, Managing Director at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 4,060 shares at $19.49 ($79K) on 2018-08-01, disclosed to the SEC on 2018-08-02.
Open-market sale of $79k ALDR by Managing Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ZYME | SELL | 2025-01-06 | $332K | — | Filing → |
| ALDR | SELL | 2019-09-18 | $1.2M | — | Filing → |
| ALDR | SELL | 2018-12-04 | $140K | — | Filing → |